 SALT LAKE CITY, Aug. 30, 2021 GLOBE NEWSWIRE -- Sera Prognostics Inc., The Pregnancy CompanyTM Nasdaq: SERA, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2021. 